Cerity Partners’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$384K	Buy	157,235 +59,326	+61%	+$119K	﹤0.01%	2446
2025 Q4	$134K	Sell	97,909 -368,823	-79%	-$487K	﹤0.01%	2710
2025 Q3	$579K	Buy	466,732 +66,465	+17%	+$79.2K	﹤0.01%	1881
2025 Q2	$452K	Buy	400,267 +19,843	+5%	+$26.4K	﹤0.01%	1917
2025 Q1	$555K	Sell	380,424 -6,963	-2%	-$13.1K	﹤0.01%	1703
2024 Q4	$832K	Sell	387,387 -44,995	-10%	-$111K	﹤0.01%	1506
2024 Q3	$1.21M	Buy	432,382 +232	+0.1%	+$618	﹤0.01%	1314
2024 Q2	$1.01M	Buy	432,150 +7,981	+2%	+$23.5K	﹤0.01%	1224
2024 Q1	$1.9M	Sell	424,169 -93,412	-18%	-$390K	0.01%	994
2023 Q4	$1.66M	Buy	+517,581	New	+$1.47M	0.01%	819
2023 Q3	–	Sell	-598,100	Closed	-$2.97M	–	1400
2023 Q2	$2.97M	Sell	598,100 -1,954	-0.3%	-$10.6K	0.01%	625
2023 Q1	$2.96M	Buy	600,054 +10,800	+2%	+$69.3K	0.01%	603
2022 Q4	$3.71M	Sell	589,254 -41,171	-7%	-$381K	0.02%	413
2022 Q3	$6.81M	Buy	630,425 +29,411	+5%	+$400K	0.08%	202
2022 Q2	$6.85M	Sell	601,014 -100,039	-14%	-$888K	0.08%	214
2022 Q1	$6.39M	Sell	701,053 -2,333	-0.3%	-$24.3K	0.1%	169
2021 Q4	$10.5M	Buy	703,386 +305,334	+77%	+$5.39M	0.16%	119
2021 Q3	$10.2M	Sell	398,052 -2,100	-0.5%	-$49.9K	0.23%	96
2021 Q2	$10.4M	Sell	400,152 -1,450	-0.4%	-$41.4K	0.23%	89
2021 Q1	$14.2M	Buy	+401,602	New	+$13.5M	0.34%	63